Web notes  

July 2016
FUNDING OPPORTUNITIES- Back

Lupus Research Institute - Dr. William E. Paul Distinguished Innovator Awards in Lupus and Autoimmunity

Grant Application Deadline: July 8, 2016

The Lupus Research Institute (LRI) invites applications for its Dr. William E. Paul Distinguished Innovator Awards in Lupus and Immunology, a global program that will provide outstanding scientists with substantial support for up to four years to conduct novel research into the fundamental causes of lupus and so provide new directions toward a cure or prevention.

Advances across many disciplines have led to novel treatments that aim to suppress the manifestations of lupus. Yet few interventions are being developed that seek to reverse or prevent the disease. LRI Distinguished Innovators will address this gap by pioneering research into the fundamental, causative pathways of lupus.

In pursuit of this goal, the LRI welcomes novel, hypothesis- or discovery-driven proposals in human and/or animal model based lupus research. The research proposal must aim to uncover the fundamental causes of lupus and present a compelling vision of how the discovery would lay the groundwork for a potential cure, prevention, or highly effective therapy.

Successful applicants will be outstanding investigators who have demonstrated creativity and productivity in their field of research. We encourage applications from investigators in diverse disciplines including, but not limited to, immunology, genetics, molecular-, cell- and systems biology. Scientists who have not previously worked in lupus are encouraged to apply, as are researchers working outside the US. Applicants must hold a position at an academic institution.

Annual funding of up to $250,000 per year, for a term of up to four years, will be awarded for approved projects. We anticipate that no more than four Distinguished Innovator Awards will be made in 2016. The full grant application, including a research plan of no more than six pages is due by July 8, 2016.

Full guidelines are available at www.lupusresearchinstitute.org. For additional information contact Laura Hack, Grants Administrator, researchadmin@lupusny.org or +1 (212) 218 2840.

To submit an Application, please visit proposal Central at http://proposalcentral.altum.com/.


NIH Director's Early Independence Awards (DP5)

Internal Deadline: 4 pm, July 11, 2016

The NIH Director's Early Independence Awards provide an opportunity for exceptional junior scientists to accelerate their entry into an independent research career by forgoing the traditional post-doctoral training period. Though most newly graduated doctoral-level researchers would benefit by post-doctoral training, a small number of outstanding junior investigators would benefit instead by launching directly into an independent research career. For these select investigators, who have established a record of scientific innovation and research productivity and who have demonstrated unusual leadership, drive, and maturity, post-doctoral training would unnecessarily delay their entry into performing independent research.

The NIH Director's Early Independence Awards also provide an opportunity for institutions to invigorate their research programs by bringing in the fresh perspectives of the awardees that they host. By the end of the award period, the Early Independence investigator is expected to be competitive for continued funding of his/her research program and for a permanent research position.

Eligibility & Requirements:

  • At the time of application, the individual either 1) within the preceding twelve months must have received a terminal doctoral degree or completed medical residency or 2) within the following twelve months must complete all the requirements for a doctoral degree or complete a medical residency. The fellowship training period is NOT included in the clinical residency or equivalent training period.
  • At the time of award to the grantee Institution, either 1) the Early Independence investigator must have received a PhD, MD, DO, or equivalent doctoral degree from an accredited domestic or foreign institution (it is the responsibility of the sponsoring institution to determine if a foreign doctoral degree is equivalent), OR 2) an authorized official of the degree-granting institution must certify that all degree requirements have been met and that the date of graduation as appearing on the transcript will be within one year of the date of application submission.
  • The candidate must not already be a PD/PI on an NIH R01 or R01-equivalent award.
  • See full eligibility based on research independence here.

Internal Nomination Process:
Interested applicants should send the following documents in sequence in one PDF to resapp@jhu.edu
no later than 4 p.m. on July 11, 2016:

  1. JHU Limited Submission Cover Sheet
  2. Abstract (one page, double-spaced)
  3. Proposal (maximum of four pages of text only, single spaced: 12-pt font and one-inch margins) (Note: figures, tables, and other reference material should not be included as text)
  4. Curriculum Vitae of investigator, including current external research support and publications
  5. Budget (two pages maximum)
  6. Letter of Recommendation from the Department Chair/Director: Letters of Recommendation can be submitted separately to resapp@jhu.edu stating applicant's name in the subject line. Each applicant should expect to receive a confirmation of receipt of their materials. If an applicant does not receive an acknowledgement, or has any questions, please contact Brittany McMahon via resapp@jhu.edu.


BrightFocus Foundation Macular Degeneration Research Program

Letter of Intent deadline: July 19, 2016

The standard award provides significant funding for researchers who have already generated some amount of preliminary data, but are often required to demonstrate additional, significant progress before they can apply to governmental or industrial funding agencies. Learn more about this funding opportunity here.

Maximum award value: $160,000
Maximum duration: 2 years


Burroughs Wellcome Fund - Investigators in the Pathogenesis of Infectious Disease Award

Application deadline: July 15, 2016, 4:00 pm ET

The Investigators in the Pathogenesis of Infectious Disease (PATH) award provides $500,000 over five years to support accomplished investigators at the assistant professor level to study pathogenesis, with a focus on the interplay between human and microbial biology, shedding light on how human and microbial systems are affected by their encounters.

PATH is a highly competitive award program that provides $500,000 over a period of five years to support accomplished investigators at the assistant professor level to study pathogenesis. The awards are intended to give recipients the freedom and flexibility to pursue new avenues of inquiry, stimulating higher risk research projects that hold potential for significantly advancing understanding of how infectious diseases work and how health is maintained.

The competition will employ a two-stage process. Pre-proposals will be reviewed and full proposal invitations will be sent by September 23, 2016.

All applicants will be required to complete a web-based questionnaire assessing their eligibility to apply for this award. If eligibility criteria are met, applicants will be automatically directed to the web-based pre-proposal form.

It is strongly recommended that potential applicants review the Request for Proposals prior to accessing the eligibility questionnaire. For more details and application materials, visit the PATH website.


Armenise-Harvard Career Development Award (CDA)

Application deadline: July 15, 2016

The purpose of the Giovanni Armenise-Harvard Foundation is to support the research of promising young scientists, to contribute to the creation of new areas of research in the biological sciences in Italy, and to strengthen and develop collaborative relationships between Italian scientists and those at Harvard Medical School in Boston (HMS).

The Career Development Award consists of three-to-five years of funding allocated to an independent investigator at a host institute in Italy. The program is aimed at young and talented scientists, to enable them to contribute significantly to their areas of research. Funding will become available July 1, 2017. Applicants must:

  • be young emerging basic scientists with demonstrated productivity and the ability to function as an independent investigator (Previous experience working with or at HMS is desirable but not an essential requirement)
  • have a minimum of three years of post-doctoral research experience in basic biological sciences (including at least two years abroad ) and be no more than 10 years from having received a PhD, i.e. the degree should have been received no earlier than July 15, 2006 and no later than July 15, 2013
  • be researchers outside of Italy (both in the application stage and at the time of acceptance of the award), who wish to become part of the community of researchers in Italy
  • have an agreement for the development of a novel research project in a suitable host institution in Italy (preferably other than the institution where the candidate has already done doctoral study, post-doctoral research or held a job)
  • not have a pre-existing contract, independent of this grant, with a prospective host institute in Italy. Applications from candidates who have already been offered an appointment at an Italian host institute will not be considered.

The Career Development Award is $200,000 per year and the funds may cover the costs related to compensation of the researcher (commensurate with the position occupied at the host institution), salaries of the other members involved in the indicated research project, and equipment/infrastructure.

The Career Development Award Program intends to enable researchers to join the Italian scientific community to pursue a specific research project. Therefore, the nominee cannot accept concurrent grants in support of the same research project at the host institution. Exceptions to this may be made only under exceptional circumstances and should be communicated promptly to the Armenise-Harvard Foundation.

Further information and application forms for all programs are available at: Career Development Award or by contacting Elisabetta Vitali, The Giovanni Armenise-Harvard Foundation (617.432.6258 or Elisabetta_vitali@hms.harvard.edu).


Department of Defense Peer Reviewed Medical Research Program (PRMRP) Funding Opportunities for Fiscal Year 2016

The FY16 PRMRP Program Announcements and General Application Instructions are posted on Grants.gov. The FY16 PRMRP will solicit research applications for the following 39 topic areas:

  • Acute Lung Injury
  • Antimicrobial Resistance
  • Chronic Migraine and Post-Traumatic Headache
  • Congenital Heart Disease
  • Constrictive Bronchiolitis
  • Diabetes
  • Dystonia
  • Emerging Infectious Diseases
  • Focal Segmental Glomerulosclerosis
  • Fragile X Syndrome
  • Hepatitis B
  • Hereditary Angioedema
  • Hydrocephalus
  • Inflammatory Bowel Disease
  • Influenza
  • Integrative Medicine
  • Interstitial Cystitis
  • Lupus
  • Malaria
  • Metals Toxicology
  • Mitochondrial Disease
  • Nanomaterials for Bone Regeneration
  • Nonopioid Pain Management
  • Pancreatitis
  • Pathogen-Inactivated Dried Plasma
  • Polycystic Kidney Disease
  • Post-Traumatic Osteoarthritis
  • Psychotropic Medications
  • Pulmonary Fibrosis
  • Respiratory Health
  • Rett Syndrome
  • Rheumatoid Arthritis
  • Scleroderma
  • Sleep Disorders
  • Tinnitus
  • Tuberculosis
  • Vaccine Development for Infectious Disease
  • Vascular Malformations
  • Women's Heart Disease

Military Relevance: Relevance to the healthcare needs of the military Service members, Veterans, and beneficiaries is a key feature of each FY16 PRMRP award mechanism.

Discovery Award - Deadline 7/21/16

  • All Investigators
  • Supports the exploration of a highly innovative new concept or untested theory.
  • Not intended to support the logical progression of an already established line of questioning.
  • Clinical trials will not be funded.
  • Reviewers will be blinded to the identity of the Principal Investigator (PI), collaborators, and their organization(s)
  • Maximum of $200,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 18 months

Investigator-Initiated Research Award - Deadline 10/19/16

  • Assistant Professor level or above (or equivalent)
  • Supports research that will make an original and important contribution to the field of research or patient care in the topic area(s) of interest.
  • Partnering PI Option available.
  • Clinical trials will not be funded.
  • Preproposal submission is required; application submission is by invitation only.
  • Maximum of $1.2 million for direct costs (plus indirect costs)
  • Maximum of $1.5 million for direct costs (plus indirect costs) for applications including a Partnering PI Option
  • Maximum period of performance is 3 years

Technology/ Therapeutic Development Award Assistant Professor level or above (or equivalent) - Deadline 10/19/16

  • Supports the development of diagnostics or therapies that have the potential to make a strong impact on patient care in the topic area(s) of interest.
  • Product-oriented (e.g., device, drug, clinical guidelines).
  • Clinical trials will not be funded.
  • Preproposal submission is required; application submission is by invitation only
  • Maximum of $3.0 million for direct costs (plus indirect costs)
  • Maximum period of performance is 3 years

Focused Program Award - Deadline 10/21/16

  • Full Professor level or above (or equivalent)
  • Supports a synergistic, multidisciplinary research program of at least four distinct but complementary projects addressing an overarching goal in one of the topic areas listed directly above. Projects should work together to answer critical questions, resolve differing hypotheses, and translate laboratory findings to clinical applications. Projects may range from exploratory/ hypothesis-developing through small-scale clinical trials that together will address the overarching goal/question. Research team of highly qualified, multidisciplinary project leaders should be led by a PI with demonstrated success in directing large, focused projects.
  • Preproposal submission is required; application submission is by invitation only.
  • Maximum of $10 million for total costs (includes direct and indirect costs)
  • Maximum period of performance is 5 years

Clinical Trial Award - Deadline 10/26/16

  • Assistant Professor level or above (or equivalent)
  • Supports the rapid implementation of clinical trials of novel interventions with the potential to have a significant impact on patient care in the topic area(s) of interest.
  • Proposed projects may range from small proof-of-concept trials through large-scale, definitive trials.
  • Investigational New Drug or Investigational Device Exemption applications, if needed, should be submitted to the Food and Drug Administration before the PRMRP Grants.gov application submission deadline.
  • Preproposal submission is required; application submission is by invitation only
  • Funding limit not defined; requested funding must be appropriate for the scope of work proposed
  • Maximum period of performance is 5 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from Grants.gov. The application package containing the required forms for each award mechanism will also be found on Grants.gov, and applications must be submitted through Grants.gov. Requests for email notification of the Program Announcements' release may be sent to help@ebrap.org For more information about the PRMRP or other CDMRP-administered programs, please visit the CDMRP website.


Searle Scholars Program

Internal application deadline: July 22, 2016

The Searle Scholars Program supports research of outstanding individuals who have recently begun their appointment at the Assistant Professor level, and whose appointment is their first tenure-track position at a participating academic or research institution.

Eligibility & Requirements:

  • Applicants for awards, which will be activated on July 1, 2017, will be expected to be pursuing independent research careers in biochemistry, cell biology, genetics, immunology, neuroscience, pharmacology, and related areas in chemistry, medicine, and the biological sciences.
  • Applicants should have begun their appointment as an independent investigator at the Assistant Professor level on or after July 1, 2015. The appointment must be their first tenure-track position (or its nearest equivalent) at JHU.
  • Applicants who were nominated for awards in the previous competition year but were not awarded may still meet the eligibility criteria for the current competition.
  • The Searle Scholars Program does not ordinarily support purely clinical research but has supported research programs that include both clinical and basic components.

Internal Nomination Process:
Interested applicants should send the following documents in sequence in one PDF to resapp@jhu.edu no later than 4 p.m. on July 22, 2016:

  1. JHU Limited Submission Cover Sheet
  2. Abstract (one page, double-spaced)
  3. Proposal (maximum of four pages of text only, single spaced: 12-pt font and one-inch margins) (Note: figures, tables, and other reference material may be included in addition to the 4 pg. text limit)
  4. Curriculum Vitae of investigator, including current external research support and publications
  5. Budget (two pages maximum)
  6. Letter of Recommendation from the Department Chair/Director. Letters of Recommendation can be submitted separately to resapp@jhu.edu stating the applicant's name in the subject line.

Each applicant should expect to receive a confirmation of receipt of their materials. Applicants not receiving an acknowledgement, or having any questions, should contact Brittany McMahon via resapp@jhu.edu.


Otolaryngology Head & Neck Cancer SPORE - Developmental Research Program Pilot Project Solicitation

Deadline: July 30, 2016

The Johns Hopkins Otolaryngology Head & Neck Cancer Research Division is soliciting applications to support new pilot projects in Head and Neck cancer related research. Funds for the Developmental Research Program are provided by the NIDCR Head and Neck Cancer SPORE grant. The Program has been a major focus of the SPORE because it provides for a continuous flow of innovative ideas and activity to stimulate investigation in the context of SPORE translational research. The Developmental Research Program provides a means to respond to new opportunities, and is designed to encourage and facilitate new research efforts.

Applications are limited to 2 pages and should include the following:

  • abstract
  • budget summary- $25K Max Direct Costs (budgets exceeding this amount will not be accepted)
  • Biosketch (not included in 2 page maximum)

Applications will be reviewed and awarded before 9/1/16. Please send your completed application to: Faye H. Mackall (fmackal1@jhmi.edu).


Fondation Leducq Transatlantic Networks of Excellence Program

Application deadline: September 6, 2016

The Fondation Leducq, a private French research foundation dedicated to promoting international research in cardiovascular and neurovascular disease, is issuing a new call for applications for its 2016-2017 Transatlantic Networks of Excellence Program.

Please note that applicants to the Transatlantic Networks Program must submit a letter of intent (LOI) through the online application service managed by Altum proposalCENTRAL.

This program awards up to U.S. $6 million over five years to internationally collaborative research teams who work together to advance our knowledge and treatment of cardiovascular and neurovascular disease.



Burroughs Wellcome Fund - Career Awards at the Scientific Interface

Application deadline: September 6, 2016

BWF's Career Awards at the Scientific Interface (CASI) provide $500,000 over five years to bridge advanced postdoctoral training and the first three years of faculty service. These awards are open to U.S. and Canadian citizens or permanent residents as well as to U.S. temporary residents.

These grants are intended to foster the early career development of researchers who have transitioned or are transitioning from undergraduate and/or graduate work in the physical/mathematical/computational sciences or engineering into postdoctoral work in the biological sciences, and who are dedicated to pursuing a career in academic research.

The competition will employ a two-stage process. Preproposals will be reviewed and full proposal invitations will be sent by November 14, 2016.

All applicants will be required to complete a web-based questionnaire assessing their eligibility to apply for this award. If eligibility criteria are met, applicants will be automatically directed to the web-based pre-proposal form.

It is strongly recommended that potential applicants review the Request for Proposals prior to accessing the eligibility questionnaire.

For a full explanation of the eligibility requirements and application instructions and forms, visit the CASI website.


Department of Defense Prostate Cancer Research Program (PCRP)

The PCRP's FY16 mission is to find and fund research that will lead to the elimination of death and enhance the well-being of men with prostate cancer. A synopsis of the Prostate Cancer Research Programs appears here.

Clinical Consortium Research Site Award
Pre-proposal deadline: September 15, 2016

Independent investigators at or above the level of Assistant Professor (or equivalent)

  • Supports the addition of a Clinical Research Site to the Prostate Cancer Clinical Trials Consortium.

This consortium facilitates the rapid execution of collaborative Phase II or Phase I/II clinical trials that will bring to market high-impact, novel therapeutic interventions that will ultimately and significantly decrease the impact of prostate cancer.

  • Funds may not be used for research or development of clinical protocols.
  • Sites must provide plans for accruing patients from populations disproportionately affected by prostate cancer.
  • Trials that incorporate investigations of biomarkers for risk assessment, early detection, prediction of aggressiveness, and/or progression of prostate cancer are encouraged.
  • Maximum funding of $600K for direct costs (plus indirect costs)
    · Maximum period of performance is 3 years

Complete details are available at the Clinical Consortium Research Site Award website. A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism are also found on Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the federal government's single-entry portal,Grants.gov. Requests for email notification of the Program Announcements release may be sent to help@cdmrp.org. For more information about the PCRP or other CDMRP-administered programs, please visit the CDMRP website(http://cdmrp.army.mil).


Burroughs Wellcome Fund - Career Awards for Medical Scientists

Application deadline: October 6, 2016

The Career Awards for Medical Scientists (CAMS) is a highly competitive program that provides $700,000 awards over five years for physician-scientists, who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service.

Proposals must be in the area of basic biomedical, disease-oriented, or translational research. Proposals in health services research or involving large-scale clinical trials are not eligible. The previously funded individuals (or researchers) are listed in the Grant Recipients section of this program.

All applicants will be required to complete a web-based questionnaire assessing their eligibility to apply for this award. If eligibility criteria are met, applicants will be automatically directed to the web-based pre-proposal form.

It is strongly recommended that potential applicants review the Request for Proposals prior to accessing the eligibility questionnaire.

For a full explanation of the eligibility requirements, view the Request for Proposals. For application instructions and forms, visit the CAMS website.

Note: BWF will make up to two additional awards to clinically trained psychiatrists who focus on research at the interface between neuroscience and psychiatry. These proposals must clearly demonstrate evidence of integration of neuroscience and psychiatry in project design.


Michael J. Fox Foundation (MJFF) Challenge

No application deadline

The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.

The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson's disease (PD) field. The accumulation of aggregated alpha-synuclein is a pathological hallmark of PD and a priority target for drug development given its hypothesized contribution to neurodegeneration. In vivo imaging of alpha-synuclein pathology could be useful as a biomarker of the presence of disease and disease progression and as a pharmacodynamic tool for drug development. With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.

Contestants: Anyone is eligible for the prize who agrees to all contest rules. Contestants may be MJFF funded or not and can be from either academia or industry.

Contest rules:

  1. Contestants must apply for the prize with pre-clinical and clinical data supporting the broad use of their alpha-synuclein radiotracer. Judges may ask for additional data, including but not limited to raw imaging data.
  2. NOTE: All contestants must agree to make the winning radiotracer available for use by The Michael J. Fox Foundation and MJFF awardees through a nonexclusive license or other MJFF-approved mechanism.

Criteria for winning: The winning contestant must demonstrate that the radiotracer binds with relatively high selectivity to alpha-synuclein according to pre-specified criteria and must demonstrate proof-of-concept in human subjects, including people with Parkinson's disease and/or another synucleinopathy. See below for more details on submission requirements.

Timeline: There is no deadline for submissions. The $2 million award will be issued to the first contestant who submits compelling evidence of a viable selective tracer and agrees to its widespread use. If no award is given by mid-2018, The Michael J. Fox Foundation will evaluate the state of the field and utility of such a prize.


Return to top of Funding Opportunities

 
   
July 2016 articles:
JHM Policy Governing Use of Human Biospecimens to Derive Immortalized or Pluripotent Stem Cell Lines
Johns Hopkins Institute for Clinical and Translational Research
Johns Hopkins Research Network
JHM HSR Recertification Training
 
Visit Animal Care and Use Committee Website
Current Classes
"Interinstitutional Assurance" Agreement
Health, Safety, and Environment (HSE) presents: Safety in Research Updates
Lupus Research Institute - Dr. William E. Paul Distinguished Innovator Awards in Lupus and Autoimmunity
NIH Director's Early Independence Awards (DP5)
BrightFocus Foundation Macular Degeneration Research Program
Burroughs Wellcome Fund - Investigators in the Pathogenesis of Infectious Disease Award
Armenise-Harvard Career Development Award (CDA)
Department of Defense Peer Reviewed Medical Research Program (PRMRP) Funding Opportunities for Fiscal Year 2016
Searle Scholars Program
Otolaryngology Head & Neck Cancer SPORE - Developmental Research Program Pilot Project Solicitation
Fondation Leducq Transatlantic Networks of Excellence Program
Burroughs Wellcome Fund - Career Awards at the Scientific Interface
Department of Defense Prostate Cancer Research Program (PCRP)
Burroughs Wellcome Fund - Career Awards for Medical Scientists
Michael J. Fox Foundation (MJFF) Challenge
NIH Policy: Foreign Components Added to a Grant to a Domestic or Foreign Organization

This Month's Departmental Listings

Upcoming Deadlines for August and September

July Events at the Genetic Resources Core Facility
       

 

JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 

 

                                                                                                                                                           The Web Center